Also affiliated with Third Xiangya Hospital, Icahn School of Medicine at Mount Sinai
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.
Cai Qingsong, Ma Kejia, Wu Xing, Cai Lixia, Deng Minzi +9 more
Driven by 7 papers — median percentile 45. Top paper: “Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial”.
Siamak Daneshmand, Sudeh Izadmehr, Edgar Gonzalez‐Kozlova, Kevin Chan, Sara Lewis +35 more
Marina Ruiz de Galarreta, Melissa A. Yao, Katherine E. Lindblad, Erin Bresnahan, Elizabeth Bitterman +20 more
Jiahao Xu, Jingbo Li, Minzi Deng, Zhaohua Shen, Kai Nie +6 more
Edgar Gonzalez‐Kozlova, Chen‐Yang Su, Sirui Zhou, Tomoko Nakanishi, Elsa Brunet‐Ratnasingham +91 more
Cai Qingsong, Ma Kejia, Wu Xing, Cai Lixia, Deng Minzi +9 more
Matthew Brown, Leandra Velazquez, Marcus Thomas, E. A. Wilson, Timothy J. O’Donnell +34 more
Matthew Brown, Leandra Velazquez, Marcus Thomas, E. A. Wilson, Timothy J. O’Donnell +34 more